dr rx ltd
dr rx ltd Company Information
Company Number
10591116
Next Accounts
Oct 2025
Industry
Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
Directors
Shareholders
tony emme
Group Structure
View All
Contact
Registered Address
3 george street, watford, WD18 0BX
Website
prescribedirect.comdr rx ltd Estimated Valuation
Pomanda estimates the enterprise value of DR RX LTD at £185.5k based on a Turnover of £566.6k and 0.33x industry multiple (adjusted for size and gross margin).
dr rx ltd Estimated Valuation
Pomanda estimates the enterprise value of DR RX LTD at £2.4m based on an EBITDA of £602.2k and a 4.06x industry multiple (adjusted for size and gross margin).
dr rx ltd Estimated Valuation
Pomanda estimates the enterprise value of DR RX LTD at £3.6m based on Net Assets of £1.4m and 2.57x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dr Rx Ltd Overview
Dr Rx Ltd is a live company located in watford, WD18 0BX with a Companies House number of 10591116. It operates in the retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. sector, SIC Code 47749. Founded in January 2017, it's largest shareholder is tony emme with a 100% stake. Dr Rx Ltd is a young, small sized company, Pomanda has estimated its turnover at £566.6k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dr Rx Ltd Health Check
Pomanda's financial health check has awarded Dr Rx Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 8 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
8 Weak
Size
annual sales of £566.6k, make it smaller than the average company (£11.6m)
- Dr Rx Ltd
£11.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 7%, show it is growing at a slower rate (8.5%)
- Dr Rx Ltd
8.5% - Industry AVG
Production
with a gross margin of 30.5%, this company has a higher cost of product (39.4%)
- Dr Rx Ltd
39.4% - Industry AVG
Profitability
an operating margin of 106.3% make it more profitable than the average company (6.4%)
- Dr Rx Ltd
6.4% - Industry AVG
Employees
with 4 employees, this is below the industry average (26)
4 - Dr Rx Ltd
26 - Industry AVG
Pay Structure
on an average salary of £51.5k, the company has an equivalent pay structure (£51.5k)
- Dr Rx Ltd
£51.5k - Industry AVG
Efficiency
resulting in sales per employee of £141.7k, this is less efficient (£285.9k)
- Dr Rx Ltd
£285.9k - Industry AVG
Debtor Days
it gets paid by customers after 82 days, this is later than average (52 days)
- Dr Rx Ltd
52 days - Industry AVG
Creditor Days
its suppliers are paid after 79 days, this is slower than average (47 days)
- Dr Rx Ltd
47 days - Industry AVG
Stock Days
it holds stock equivalent to 463 days, this is more than average (59 days)
- Dr Rx Ltd
59 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 9 weeks, this is less cash available to meet short term requirements (15 weeks)
9 weeks - Dr Rx Ltd
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 9.8%, this is a lower level of debt than the average (48.6%)
9.8% - Dr Rx Ltd
48.6% - Industry AVG
DR RX LTD financials
Dr Rx Ltd's latest turnover from January 2024 is estimated at £566.6 thousand and the company has net assets of £1.4 million. According to their latest financial statements, Dr Rx Ltd has 4 employees and maintains cash reserves of £15 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | |
|---|---|---|---|---|---|---|---|
| Turnover | |||||||
| Other Income Or Grants | |||||||
| Cost Of Sales | |||||||
| Gross Profit | |||||||
| Admin Expenses | |||||||
| Operating Profit | |||||||
| Interest Payable | |||||||
| Interest Receivable | |||||||
| Pre-Tax Profit | |||||||
| Tax | |||||||
| Profit After Tax | |||||||
| Dividends Paid | |||||||
| Retained Profit | |||||||
| Employee Costs | |||||||
| Number Of Employees | 4 | 4 | 3 | 2 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 533,200 | 202,365 | 165,398 | 55,676 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 299,300 | 177,475 | 1 | 1 | 1 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 832,500 | 379,840 | 165,399 | 55,677 | 1 | 0 | 0 |
| Stock & work in progress | 500,430 | 442,300 | 325,787 | 0 | 0 | 0 | 0 |
| Trade Debtors | 127,888 | 28,500 | 0 | 178,654 | 0 | 1 | 1 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 7,390 | 0 | 0 | 0 |
| Cash | 15,000 | 3,200 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 55,680 | 23,425 | 78,320 | 0 | 0 | 0 | 0 |
| total current assets | 698,998 | 497,425 | 404,107 | 186,044 | 0 | 1 | 1 |
| total assets | 1,531,498 | 877,265 | 569,506 | 241,721 | 1 | 1 | 1 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 85,543 | 45,332 | 16,920 | 6,800 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 85,543 | 45,332 | 16,920 | 6,800 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 53,887 | 38,268 | 25,128 | 3,650 | 0 | 0 | 0 |
| provisions | 10,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 63,887 | 38,268 | 25,128 | 3,650 | 0 | 0 | 0 |
| total liabilities | 149,430 | 83,600 | 42,048 | 10,450 | 0 | 0 | 0 |
| net assets | 1,382,068 | 793,665 | 527,458 | 231,271 | 1 | 1 | 1 |
| total shareholders funds | 1,382,068 | 793,665 | 527,458 | 231,271 | 1 | 1 | 1 |
| Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | |||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | ||
| Amortisation | 0 | 0 | 0 | 0 | 0 | ||
| Tax | |||||||
| Stock | 58,130 | 116,513 | 325,787 | 0 | 0 | 0 | 0 |
| Debtors | 99,388 | 28,500 | -186,044 | 186,044 | -1 | 0 | 1 |
| Creditors | 40,211 | 28,412 | 10,120 | 6,800 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 10,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | 121,825 | 177,474 | 0 | 0 | 1 | 0 | 0 |
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 15,619 | 13,140 | 21,478 | 3,650 | 0 | 0 | 0 |
| share issue | |||||||
| interest | |||||||
| cash flow from financing | |||||||
| cash and cash equivalents | |||||||
| cash | 11,800 | 3,200 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 11,800 | 3,200 | 0 | 0 | 0 | 0 | 0 |
dr rx ltd Credit Report and Business Information
Dr Rx Ltd Competitor Analysis
Perform a competitor analysis for dr rx ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in WD18 area or any other competitors across 12 key performance metrics.
dr rx ltd Ownership
DR RX LTD group structure
Dr Rx Ltd has no subsidiary companies.
Ultimate parent company
DR RX LTD
10591116
dr rx ltd directors
Dr Rx Ltd currently has 1 director, Mr Tony Emme serving since Dec 2021.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Tony Emme | England | 36 years | Dec 2021 | - | Director |
P&L
January 2024turnover
566.6k
+40%
operating profit
602.2k
0%
gross margin
30.5%
+1.28%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
1.4m
+0.74%
total assets
1.5m
+0.75%
cash
15k
+3.69%
net assets
Total assets minus all liabilities
Similar Companies
dr rx ltd company details
company number
10591116
Type
Private limited with Share Capital
industry
47749 - Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
incorporation date
January 2017
age
7
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
January 2024
previous names
prescribe direct limited (February 2023)
accountant
-
auditor
-
address
3 george street, watford, WD18 0BX
Bank
-
Legal Advisor
-
dr rx ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dr rx ltd.
dr rx ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DR RX LTD. This can take several minutes, an email will notify you when this has completed.
dr rx ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
